Cestode vaccines: Origins, current status and future prospects

Parasitology

Volumn 133, Issue SUPPL.2, 2006, Pages

  Lightowlers, M W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cysticercosis; Echinococcosis; Echinococcus; Hydatidosis; Orphan vaccine; Taenia; Vaccine

Indexed keywords

EG95 VACCINE; IMMUNOLOGICAL ADJUVANT; ORPHAN DRUG; PARASITE ANTIGEN; RECOMBINANT VACCINE; TSA18 ANTIGEN; TSA9 ANTIGEN; TSOL18 VACCINE; TSOL45 1A ANTIGEN; TSOL45 ANTIGEN; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; CATTLE; CESTODE; CESTODIASIS; COMMERCIAL PHENOMENA; CYSTICERCOSIS; DEVELOPING COUNTRY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG MECHANISM; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; ECONOMIC ASPECT; HUMAN; IMMUNITY; INFECTION CONTROL; INFECTION PREVENTION; INFECTION SENSITIVITY; LIVESTOCK; METACESTODE; METAZOON; NEUROCYSTICERCOSIS; NONHUMAN; PARASITOSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCALE UP; SHEEP; SOCIOECONOMICS; SWINE; TAENIA OVIS; TAENIA SAGINATA; TAENIA SOLIUM; TAENIASIS;

ANIMALS; CESTODA; CESTODE INFECTIONS; COST OF ILLNESS; CYSTICERCOSIS; DISEASE SUSCEPTIBILITY; ECHINOCOCCOSIS; HUMANS; TAENIASIS; VACCINATION;

ANIMALIA; BOS; CESTODA; ECHINOCOCCUS; ECHINOCOCCUS GRANULOSUS; OVIS ARIES; SUIDAE; TAENIA; TAENIA OVIS; TAENIA SAGINATA; TAENIA SOLIUM;

EID: 33846842379     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S003118200600179X     Document Type: Review

References (93)

1. Batson, A. (2002). The costs and economics of modern vaccine development. Developments in Biologicals 110, 15-24.
2. Biggs, M. W. and Eiselein, J. E. (1965). Diffusion chamber studies of allogenic tumor immunity in mice. Cancer Research 25, 1888-1893.
3. Boa, M., Mukaratirwa, S., Willingham, A. L. and Johansen, M. V. (2003). Regional action plan for combating Taenia solium cysticercosis/taeniosis in Eastern and Southern Africa. Acta Tropica 87, 183-186.
4. Bogh, H. O., Lightowlers, M. W., Sullivan, N. D., Mitchell, G. F. and Rickard, M. D. (1990). Stage-specific immunity to Taenia taeniaeformis infection in mice. A histological study of the course of infection in mice vaccinated with either oncosphere or metacestode antigens. Parasite Immunology 12, 153-162.
5. Bogh, H. O., Rickard, M. D. and Lightowlers, M. W. (1988). Studies on stage-specific immunity against Taenia taeniaeformis metacestodes in mice. Parasite Immunology 10, 255-264.
6. Budke, C. M., Jiamin, Q., Zinsstag, J., Qian, W. and Torgerson, P. R. (2004). Use of disability adjusted life years in the estimation of the disease burden of echinococcosis for a high endemic region of the Tibetan plateau. American Journal of Tropical Medicine and Hygiene 71, 56-64.
7. Campbell, D. H. (1936). Active immunization of albino rats with protein fractions from Taenia taeniaeformis and its larval form Cysticercus fasciolaris. American Journal of Hygiene 23, 104-113.
8. Carabin, H., Budke, C. M., Cowan, L. D., Willingham, A. L. and Torgerson, P. R. (2005). Methods for assessing the burden of parasitic zoonoses: echinococcosis and cysticercosis. Trends in Parasitology 21, 327-333.
9. Cox, F. E. G. (1993). Milestones in parasitology. Parasitology Today 9, 347-348.
10. Dempster, R. P., Berridge, M. V., Harrison, G. B. and Heath, D. D. (1991). Echinococcus granulosus: development of an intermediate host mouse model for use in vaccination studies. International Journal for Parasitology 21, 549-554.
11. Dempster, R. P., Harrison, G. B. L. and Berridge, M. V. (1995). Maternal transfer of protection from Echinococcus granulosus infection in sheep. Research in Veterinary Science 58, 197-202.
12. Dempster, R. P., Robinson, C. M. and Harrison, G. B. (1996). Parasite vaccine development: large-scale recovery of immunogenic Taenia ovis fusion protein GST-45W(B/X) from Escherichia coli inclusion bodies. Parasitology Research 82, 291-296.
13. Eckert, J., Gemmell, M. A., Meslin, F.-X. and Pawlowski, Z. S. (2001). WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. WHO/FAO, Paris.
14. Eckert, J., Gemmell, M. A. and Soulsby, E. J. L. (1981). FAO/UNEP/WHO Guidelines for the surveillance, prevention and control of echinococcosis/hydatidosis. World Health Organization, Geneva.
15. Flisser, A., Gauci, C. G., Zoli, A., Martinez-Ocana, J., Garza-Rodriguez, A., Dominguez-Alpizar, J. L., Maravilla, P., Rodriguez-Canul, R., Avila, G., Aguilar-Vega, L., Kyngdon, C., Geerts, S. and Lightowlers, M. W. (2004). Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infection and Immunity 72, 5292-5297.
16. Froyd, G. and Round, M. C. (1959). Infection of cattle with Cysticercus bovis by the injection of oncospheres. Nature 184, 1510.
17. Garcia, H. H., Gonzalez, A. E., Evans, C. A. and Gilman, R. H. (2003). Taenia solium cysticercosis. Lancet 362, 547-556.
18. Gauci, C. G., Flisser, A. and Lightowlers, M. W. (1998). A Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18 kDa antigens. International Journal for Parasitology 28, 757-760.
19. Gauci, C. G., Ito, A. and Lightowlers, M. W. (2006). Conservation of the vaccine antigen gene, TSOL18, among genetically variant isolates of Taenia solium. Molecular and Biochemical Parasitology 146, 101-104.
20. Gauci, C. G. and Lightowlers, M. W. (2001). Alternative splicing and sequence diversity of transcripts from the oncosphere stage of Taenia solium with homology to the 45W antigen of Taenia ovis. Molecular and Biochemical Parasitology 112, 173-181.
21. Gauci, C., Merli, M., Muller, V., Chow, C., Yagi, K., Mackenstedt, U. and Lightowlers, M. W. (2002). Molecular cloning of a vaccine antigen against infection with the larval stage of Echinococcus multilocularis. Infection and Immunity 70, 3969-3972.
22. Geerts, S., Kumar, V. and Abbeele, O. V. D. (1980). Taenia saginata cysticercosis in slaughter cattle in Belgium. Vlaams Diergeneeskundig Tijdschrift 49, 365-374.
23. Gemmell, M. A. (1962a). Natural and acquired immunity factors inhibiting penetration of some hexacanth embryos through the intestinal barrier. Nature 194, 701-702.
24. Gemmell, M. A. (1962b). Natural and acquired immunity factors interfering with development during the rapid growth phase of Echinococcus granulosus in dogs. Immunology 5, 495-503.
25. Gemmell, M. A. (1964a). Species specificity of the immunogenic complexes of the tapeworm hexacanth embryo. Nature 204, 705-707.
26. Gemmell, M. A. (1964b). Immunological responses of the mammalian host against tapeworm infections. I. Species specificity of hexacanth embryos in protecting sheep against Taenia hydatigena. Immunology 36, 489-499.
27. Gemmell, M. A. (1966). Immunological responses of the mammalian host against tapeworm infections. IV. Species specificity of hexacanth embryos in protecting sheep against Echinococcus granulosus. Immunology 11, 325-335.
28. Gemmell, M. A., Blundell Hasell, S. K. and MacNamara, F. N. (1969). Immunological responses of the mammalian host against tapeworm infections. IX. The transfer via colostrum of immunity to Taenia hydatigena. Experimental Parasitology 26, 52-57.
29. Gemmell, M. A., Lawson, J. R., Roberts, M. G. and Griffin, J. F. (1990). Population dynamics in echinococcosis and cysticercosis : regulation of Taenia hydatigena and T. ovis in lambs through passively transferred immunity. Parasitology 101, 145-151.
30. Gemmell, M. A. and Soulsby, E. J. (1968). The development of acquired immunity to tapeworms and progress towards active immunization, with special reference to Echinococcus spp. Bulletin of the World Health Organisation 39, 45-55.
31. Gonzalez, A. E., Gauci, C. G., Barber, D., Gilman, R. H., Tsang, V. C., Garcia, H. H., Verastegui, M. and Lightowlers, M. W. (2005). Vaccination of pigs to control human neurocysticercosis. American Journal of Tropical Medicine and Hygiene 72, 837-839.
32. Haffner, M. E. (1991). Orphan products: origins, progress, and prospects. Annual Reviews of Pharmacological Toxicology 31, 603-620.
33. Harrison, G. B., Heath, D. D., Dempster, R. P., Gauci, C., Newton, S. E., Cameron, W. G., Robinson, C. M., Lawrence, S. B., Lightowlers, M. W. and Rickard, M. D. (1996). Identification and cDNA cloning of two novel low molecular weight host-protective antigens from Taenia ovis oncospheres. International Journal for Parasitology 26, 195-204.
34. Heath, D. D. and Smyth, J. D. (1970). In vitro cultivation of Echinococcus granulosus, Taenia hydatigena, T. ovis, T. pisiformis and T. serialis from oncosphere to cystic larva. Parasitology 61, 329-343.
35. Heath, D. D. (1973a). Resistance to Taenia pisiformis larvae in rabbits. II. Temporal relationships and the development phase affected. International Journal for Parasitology 3, 491-498.
36. Heath, D. D. (1973b). Resistance to Taenia pisiformis larvae in rabbits. I. Examination of the antigenically protective phase of larval development. International Journal for Parasitology 3, 485-489.
37. Heath, D. D., Jensen, O. and Lightowlers, M. W. (2003). Progress in control of hydatidosis using vaccination - a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes. Acta Tropica 85, 133-143.
38. Heath, D. D. and Lawrence, S. B. (1981). Echinococcus granulosus cysts: early development in vitro in the presence of serum from infected sheep. International Journal for Parasitology 11, 261-266.
39. Heath, D. D. and Lawrence, S. B. (1996). Antigenic polypeptides of Echinococcus granulosus oncospheres and definition of protective molecules. Parasite Immunology 18, 347-357.
40. Heath, D. D., Lawrence, S. B. and Yong, W. K. (1979a). Cross-protection between the cysts of Echinococcus granulosus, Taenia hydatigena and T. ovis in lambs. Research in Veterinary Science 27, 210-212.
41. Heath, D. D., Lawrence, S. B. and Yong, W. K. (1992). Echinococcus granulosus in sheep: transfer from ewe to lamb of 'Arc 5' antibodies and oncosphere-killing activity, but not protection. International Journal for Parasitology 22, 1017-1021.
42. Heath, D. D., Parmeter, S. N., Osborn, P. J. and Lawrence, S. B. (1981). Resistance to Echinococcus granulosus infection in lambs. Journal of Parasitology 67, 797-799.
43. Heath, D. D., Yong, W. K., Osborn, P. J., Parmeter, S. N., Lawrence, S. B. and Twaalfhoven, H. (1979b). The duration of passive protection against Taenia ovis larvae in lambs. Parasitology 79, 177-182.
44. Heath, D. D., Qi, P., Zhang, Z., Wang, J., Feng, J. and Lightowlers, M. W. (2002). Role of immunisation of the intermediate host in hydatid disease control. Report of the PAHO/WHO Working Group on Perspectives and Possibilities of Control and Eradication of Hydatidosis, 144-148.
45. Hillyer, G. V., Chiriboga, J., Menendez-Corrada, R., Pellegrino, J. and Liard, F. (1970). An attempt to induce resistance in mice to Schistosoma mansoni infection using millipore diffusion chambers. Revista do Instituto de Medecina Tropical Sâo Paulo 12, 149-151.
46. Huerta, M., De Aluja, A. S., Fragoso, G., Toledo, A., Villalobos, N., Hernandez, M., Gevorkian, G., Acero, G., Diaz, A., Alvarez, I., Avila, R., Beltran, C., Garcia, G., Martinez, J. J., Larralde, C. and Sciutto, E. (2001). Synthetic peptide vaccine against Taenia solium pig cysticercosis : successful vaccination in a controlled field trial in rural Mexico. Vaccine 20, 262-266.
47. Jacobs, H. J., Moriarty, K. M., Charleston, W. A. G. and Heath, D. D. (1994). Resistance against Taenia hydatigena in sheep after passive transfer of serum or colostrum. Parasite Immunology 16, 351-359.
48. Johnson, K. S., Harrison, G. B., Lightowlers, M. W., O'Hoy, K. L., Cougle, W. G., Dempster, R. P., Lawrence, S. B., Vinton, J. G., Heath, D. D. and Rickard, M. D. (1989). Vaccination against ovine cysticercosis using a defined recombinant antigen. Nature 338, 585-587.
49. Kan, K. (1934). Immunological studies of Cysticercus fasciolaris. Keio Igaka 14, 663-687.
50. Kanev, I., Petrov, P., Komandarev, S., Boeva, K. V., Kurdova, R., Tanchev, T., Filipov, G. and Dinev, D. (1995). Basic helminthological issues in eastern Europe after the democratic changes. Helminthologia 32, 117-120.
51. Kerr, K. B. (1935). Immunity against a cestode parasite - Cysticercus pisiformis. American Journal of Hygiene 22, 169-182.
52. Kyngdon, C. T., Gauci, C. G., Rolfe, R. A., Velasquez Guzman, J. C., Farfan Salazar, M. J., Verastegui Pimentel, M. R., Gonzalez, A. E., Garcia, H. H., Gilmanl, R. H., Strugnell, R. A. and Lightowlers, M. W. (2006). In vitro oncosphere-killing assays to determine immunity to the larvae of Taenia pisiformis, Taenia ovis, Taenia saginata, and Taenia solium. Journal of Parasitology 92, 273-281.
53. Lang, J. and Wood, S. C. (1999). Development of orphan vaccines: an industry perspective. Emerging Infectious Diseases 5, 749-756.
54. Lawrence, S. B., Heath, D. D., Harrison, G. B. L., Robinson, C. M., Dempster, R. P., Gatehouse, T. K., Lightowlers, M. W. and Rickard, M. D. (1996). Pilot field trial of a recombinant Taenia ovis vaccine in lambs exposed to natural infection. New Zealand Veterinary Journal 44, 155-157.
55. Lightowlers, M. W., Flisser, A., Gauci, C. G., Heath, D. D., Jensen, O. and Rolfe, R. (2000). Vaccination against cysticercosis and hydatid disease. Parasitology Today 16, 191-196.
56. Lightowlers, M. W., Jensen, O., Fernandez, E., Iriarte, J. A., Woollard, D. J., Gauci, C. G., Jenkins, D. J. and Heath, D. D. (1999). Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. International Journal for Parasitology 29, 531-534.
57. Lightowlers, M. W., Lawrence, S. B., Gauci, C. G., Young, J., Ralston, M. J., Maas, D. and Heath, D. D. (1996a). Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunology 18, 457-462.
58. Lightowlers, M. W., Rickard, M. D. and Mitchell, G. F. (1986). Taenia taeniaeformis in mice: passive transfer of protection with sera from infected or vaccinated mice and analysis of serum antibodies to oncospheral antigens. International Journal for Parasitology 16, 307-315.
59. Lightowlers, M. W., Rolfe, R. and Gauci, C. G. (1996b). Taenia saginata: vaccination against cysticercosis in cattle with recombinant oncosphere antigens. Experimental Parasitology 84, 330-338.
60. Lightowlers, M. W., Waterkeyn, J. G., Rothel, J. S., Gauci, C. G. and Harrison, G. B. (1996c). Hostprotective fragments and antibody binding epitopes of the Taenia ovis 45W recombinant antigen. Parasite Immunology 18, 507-513.
61. Mikityuk, P. V. and Kuznetsova, V. N. (1991). Meat quality in cysticerciasis of cattle. Veterinariya (Moskva) 10, 62-65.
62. Miller, H. M. (1931a). Immunity in the white rat to superinfestation with Cysticercus fasciolaris. Proceedings of the Society for Experimental Biology 28, 467-468.
63. Miller, H. M. (1931b). The production of artificial immunity in the albino rat to a metazoan parasite. Journal of Preventive Medicine 5, 429-452.
64. Miller, H. M. (1932). Transmission to offspring of immunity against infection with a metazoan (cestode) parasite. Proceedings of the Royal Society for Experimental Biology 29, 1124.
65. Miller, H. M. and Gardiner, M. L. (1932). Passive immunity to infection with a metazoan parasite, Cysticercus fasciolaris, in the albino rat. Journal of Preventive Medicine 6, 479-496.
66. Miller, H. M. and Massie, E. (1932). Persistence of acquired immunity to Cysticercus fasciolaris after removal of the worms. Journal of Preventative Medicine 6, 37-46.
67. Milstien, J., Batson, A. and Meaney, W. (1997). A systematic method for evaluating the potential viability of local vaccine producers. Vaccine 15, 1358-1363.
68. Mitchell, G. F., Goding, J. W. and Rickard, M. D. (1977). Studies on immune responses to larval cestodes in mice. Increased susceptibility of certain mouse strains and hypothymic mice to Taenia taeniaeformis and analysis of passive transfer of resistance with serum. Australian Journal of Experimental Biology and Medical Science 55, 165-186.
69. Mitchell, G. F., Rajasekariah, G. R. and Rickard, M. D. (1980). A mechanism to account for mouse strain variation in resistance to the larval cestode, Taenia taeniaeformis. Immunology 39, 481-489.
70. Mobius, G. (1993). Epidemiological studies on Cysticercus bovis and Taenia saginata infections in East- and West-Germany. Deutsche Tierarztliche Wochenschrift 100, 110-114.
71. Molinari, J. L., Rodriguez, D., Tato, P., Soto, R., Arechavaleta, F. and Solano, S. (1997). Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs. Veterinary Parasitology 69, 55-63.
72. Morariu, S., Lightowlers, M. W., Cosoroaba, I., Morariu, F., Darabus, G., Ilie, M. and Belean, M. (2005). The first use in Romania of EG95 vaccine to protect sheep against hydatidosis. Revista Romana de Medicina Veterinara 15, 97-104.
73. Mukaratirwa, S., Kassuku, A. A., Willingham, A. L. and Murrell, K. D. (2003). Background to the international action planning workshop on Taenia solium cysticercosis/taeniosis with special focus on Eastern and Southern Africa. Acta Tropica 87, 3-5.
74. Murrell, K. D., Dorny, P., Flisser, A., Geerts, S., Kyvsgaard, N. C., McManus, D. P., Nash, T. E. and Pawlowski, Z. S. (2005). WHO/FAO/OIE guidelines for the surveillance, prevention and control of taeniosis/ cysticercosis. 139 pp. OIE, Paris.
75. Musoke, A. J. and Williams, J. F. (1975). Immunoglobulins associated with passive transfer of resistance to Taenia taeniaeformis in the mouse. Immunology 28, 97-101.
76. Nadzhafov, I. G. (1987). Intensity of taeniasis transmission in foci in different climatic/geographic zones of Azerbaijan: a basis for rational control measures. Meditsinskaya Parazitologiya i Parazitarnye Bolezni 2, 38-41.
77. Nemeth, I. (1970). Immunological study of rabbit cysticercosis. II. Transfer of immunity to Cysticercus pisiformis (Bloch, 1780) with parenterally administered immune serum or lymphoid cells. Acta Veterinaria Academiae Scientiarum Hungaricae 20, 69-79.
78. Nettesheim, M. P., Nakinodan, T. and Chadwick, C. J. (1966). Improved diffusion chamber cultures for cytokinetic analysis of antibody response. Immunology 11, 427-439.
79. Osborn, P. J. and Heath, D. D. (1982). Immunisation of lambs against Echinococcus granulosus using antigens obtained by incubation of oncospheres in vitro. Research in Veterinary Science 33, 132-133.
80. Petithory, J. and Rousset, J. J. (1965). Immunisation of mice against a homologous strain by living virulent trypanosomes in a diffusion chamber. Bulletin de la Société de Pathologie Exotique Filiales 58, 1049-1053.
81. rd. (2003). The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Tropica 87, 13-23.
82. Rickard, M. D. and Adolph, A. J. (1976). Vaccination of calves against Taenia saginata infection using a 'parasite-free' vaccine. Veterinary Parasitology 1, 389-392.
83. Rickard, M. D., Adolph, A. J. and Arundel, J. H. (1977). Vaccination of calves against Taenia saginata infection using antigens collected during in vitro cultivation of larvae: passive protection via colostrum from vaccinated cows and vaccination of calves protected by maternal antibody. Research in Veterinary Science 23, 365-367.
84. Rickard, M. D. and Bell, K. J. (1971a). Immunity produced against Taenia ovis and T. taeniaeformis infection in lambs and rats following in vivo growth of their larvae in filtration membrane diffusion chambers. Journal of Parasitology 57, 571-575.
85. Rickard, M. D. and Bell, K. J. (1971b). Successful vaccination of lambs against infection with Taenia ovis using antigens produced during in vitro cultivation of the larval stages. Research in Veterinary Science 12, 401-402.
86. Rickard, M. D. and Bell, K. J. (1971c). Induction of immunity of lambs to a larval cestode by diffusible antigens. Nature 232, 120.
87. Rickard, M. D. and Arundel, J. G. (1974). Passive protection of lambs against infection with Taenia ovis via colostrum. Australian Veterinary Journal 50, 22-24.
88. Rickard, M. D., Harrison, G. B., Heath, D. D. and Lightowlers, M. W. (1995). Taenia ovis recombinant vaccine - 'quo vadit '. Parasitology 110 (Suppl.), S5-S9.
89. Torgerson, P. R. (2003). The use of mathematical models to simulate control options for echinococcosis. Acta Tropica 85, 211-221.
90. Torgerson, P. R. and Heath, D. D. (2003). Transmission dynamics and control options for Echinococcus granulosus. Parasitology 127 (Suppl.), S143-S158.
91. Woollard, D. J., Gauci, C. G. and Lightowlers, M. W. (2000a). Synthetic peptides induce antibody against a host-protective antigen of Echinococcus granulosus. Vaccine 18, 785-794.
92. Woollard, D. J., Heath, D. D. and Lightowlers, M. W. (2000b). Assessment of protective immune responses against hydatid disease in sheep by immunization with synthetic peptide antigens. Parasitology 121, 145-153.
93. Woollard, D. J., Gauci, C. G., Heath, D. D. and Lightowlers, M. W. (2001). Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes. Vaccine 19, 498-507.